Design, synthesis, and evaluation of 4-(3-(3,5-dimethylisoxazol-4-yl)benzyl)phthalazin-1(2H)-one derivatives: potent BRD4 inhibitors with anti-breast cancer activity

Yingpeng Li(China Academy Of Machinery Science & Technology (China)), Jun Ge, Xinhong Chu(Tianjin University of Traditional Chinese Medicine), Yanru Deng(Tianjin University of Traditional Chinese Medicine), Hongkun Li(Qingdao University of Science and Technology), Hui Fu(Tianjin University of Traditional Chinese Medicine), Yu Yin(People's Hospital of Bishan District), Xinchi Feng(Tianjin University of Traditional Chinese Medicine)
Frontiers in Pharmacology
November 30, 2023
Cited by 3


Related Papers